Top

Japanese Journal of Ophthalmology

Published in:

01-11-2014 | Laboratory Investigation

Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period

Authors: Hidetoshi Tanioka, Yumi Kuriki, Asuka Sakamoto, Osamu Katsuta, Kouichi Kawazu, Masatsugu Nakamura

Published in: Japanese Journal of Ophthalmology | Issue 6/2014

Abstract

Purpose

P2Y₂ receptors are expressed on ocular surface tissues. Diquafosol ophthalmic solution (DIQUAS^® ophthalmic solution 3 %; Santen Pharmaceutical Co., Ltd.) acts on these receptors and promotes the secretion of water and mucin. It has been shown to be an efficient dry eye treatment. If P2Y₂ receptor expression on the ocular surface decreases with age, the effect of diquafosol may be reduced in elderly persons. In this study, we investigated the changes in P2Y₂ receptor expression on the rat ocular surface over an extended period of time.

Methods

P2Y₂ receptor expression in the conjunctiva, cornea, meibomian gland and lacrimal glands of male and female Sprague–Dawley rats was examined from 5 weeks until 53 weeks of age using immunostaining and quantitative-PCR.

Results

In the immunohistological examinations, P2Y₂ receptor expression was observed in the conjunctival epithelium containing goblet cells, corneal epithelium, meibomian gland ductal epithelium and lacrimal gland ductal epithelium. However, its expression was not significantly different between each age group or between sexes. Regarding P2Y₂ receptor mRNA expression, there was an age-related increase in the bulbar conjunctiva. In particular, a significant increase was observed in the 53-week-old age group as compared to the 5-week-old female age group. However, age-related changes in expression were not observed in the cornea or meibomian gland in males or females.

Conclusions

We observed no significant age-related decrease was observed for P2Y₂ receptor protein and mRNA expression on rat ocular surface tissues.

Fries JE, Wheeler-Schilling TH, Guenther E, Kohler K. Expression of P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes in the rat retina expression of P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes in the rat retina. Invest Ophthalmol Vis Sci. 2004;45:3410–7.PubMedCrossRef

Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–92.PubMed

Hosoya K, Ueda H, Kim KJ, Lee VH. Nucleotide stimulation of Cl(−) secretion in the pigmented rabbit conjunctiva. J Pharmacol Exp Ther. 1999;291(1):53–9.PubMed

Shiue MH, Kulkarni AA, Gukasyan HJ, Swisher JB, Kim KJ, Lee VH. Pharmacological modulation of fluid secretion in the pigmented rabbit conjunctiva. Life Sci. 2000;66:PL105–11.PubMedCrossRef

Murakami T, Fujihara T, Nakamura M, Nakata K. P2Y(2) receptor stimulation increases tear fluid secretion in rabbits. Curr Eye Res. 2000;21:782–7.PubMedCrossRef

Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555–76.PubMedCrossRef

Murakami T, Fujihara T, Nakamura M, Nakata K. P2Y(2) receptor elicits PAS-positive glycoprotein secretion from rabbit conjunctival goblet cells in vivo. J Ocul Pharmacol Ther. 2003;19:345–52.PubMedCrossRef

Pendergast W, Yerxa BR, Douglass JG 3rd, Shaver SR, Dougherty RW, Redick CC, et al. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorg Med Chem Lett. 2001;11:157–60.PubMedCrossRef

Nakamura M, Imanaka T. New treatment for dry eye: diquafosol tetrasodium. Jpn J Ocular Pharmacol. 2011;25:42–6.

10.

Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K, Diquafosol Ophthalmic Solution Phase 2 Study Group. The efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Ophthalmology. 2012;119:1954–60.PubMedCrossRef

11.

Takamura E, Tsubota K, Watanabe H, Ohashi Y, Diquafosol Ophthalmic Solution Phase 3 Study Group. A randomized, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol. 2012;96:1310–5.PubMedCentralPubMedCrossRef

12.

Yamaguchi M, Tsubota K, Watanabe H, Ohashi Y. The safety and efficacy of long-term treatment with 3% diquafosol ophthalmic solution for dry eye. J Eye. 2012;29:527–35.

13.

Koh S, Ikeda C, Takai Y, Watanabe H, Maeda N, Nishida K. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye. Jpn J Ophthalmol. 2013;57:440–6.PubMedCrossRef

14.

Tauber J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, et al. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea. 2004;23:784–92 (Erratum in Cornea. 2007; 264: 514).PubMedCrossRef

15.

Kamiya K, Nakanishi M, Ishii R, Kobashi H, Igarashi A, Sato N, et al. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Eye (Lond). 2012;26:1363–8.CrossRef

16.

Shimazaki-Den S, Iseda H, Dogru M, Shimazaki J. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Cornea. 2013;32:1120–5.PubMedCrossRef

17.

Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H, et al. Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2013;97:725–9.PubMedCentralPubMedCrossRef

18.

Johansson PA, Burnstock G, Dziegielewska KM, Guida E, McIntyre P, Saunders NR. Expression and localization of P2 nucleotide receptor subtypes during development of the lateral ventricular choroid plexus of the rat. Eur J Neurosci. 2007;25:3319–31.PubMedCrossRef

19.

Giaroni C, Knight GE, Zanetti E, Chiaravalli AM, Lecchini S, Frigo G, et al. Postnatal development of P2 receptors in the murine gastrointestinal tract. Neuropharmacology. 2006;50:690–704.PubMedCrossRef

20.

Afework M, Burnstock G. Changes in P2Y2 receptor localization on adrenaline- and noradrenaline-containing chromaffin cells in the rat adrenal gland during development and aging. Int J Dev Neurosci. 2005;23:567–73.PubMedCrossRef

21.

Miao LY, Tang JP, Esposito DP, Zhang JH. Age-related changes in P2 receptor mRNA of rat cerebral arteries. Exp Gerontol. 2001;37:67–79.PubMedCrossRef

22.

Cowlen MS, Zhang VZ, Warnock L, Moyer CF, Peterson WM, Yerxa BR. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res. 2003;77:77–84.PubMedCrossRef

23.

Ishibashi K, Okamura K, Yamazaki J. Involvement of apical P2Y₂ receptor-regulated CFTR activity in muscarinic stimulation of Cl(−) reabsorption in rat submandibular gland. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1729–36.PubMedCrossRef

24.

Coutinho-Silva R, Parsons M, Robson T, Burnstock G. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res. 2001;306:373–83.PubMedCrossRef

25.

Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci. 2001;42:96–100.PubMed

26.

Fujihara T, Murakami T, Nagano T, Nakamura M, Nakata K. INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 2002;18:363–70.PubMedCrossRef

27.

Nakamura M, Imanaka T, Sakamoto A. Diquafosol ophthalmic solution for dry eye treatment. Adv Ther. 2012;29:579–89.PubMedCrossRef

28.

Nichols KK, Yerxa B, Kellerman DJ. Diquafosol tetrasodium: a novel dry eye therapy. Expert Opin Investig Drugs. 2004;13:47–54.PubMedCrossRef

29.

Alves M, Cunha DA, Calegari VC, Saad MJ, Boschero AC, Velloso LA, et al. Nuclear factor-kappaB and advanced glycation end-products expression in lacrimal glands of aging rats. J Endocrinol. 2005;187:159–66.PubMedCrossRef

30.

Kawashima M, Kawakita T, Okada N, Ogawa Y, Murat D, Nakamura S, et al. Calorie restriction: a new therapeutic intervention for age-related dry eye disease in rats. Biochem Biophys Res Commun. 2010;397:724–8.PubMedCrossRef

Title: Expression of the P2Y2 receptor on the rat ocular surface during a 1-year rearing period
Authors: Hidetoshi Tanioka
Yumi Kuriki
Asuka Sakamoto
Osamu Katsuta
Kouichi Kawazu
Masatsugu Nakamura
Publication date: 01-11-2014
Publisher: Springer Japan
Published in: Japanese Journal of Ophthalmology / Issue 6/2014
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI: https://doi.org/10.1007/s10384-014-0342-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2014

Comparison of regression models for serial visual field analysis

Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus

Blindness following bleb-related infection in open angle glaucoma

Autologous antibodies to outer retina in acute zonal occult outer retinopathy

Scientific reviewers

Long-term outcomes of 3 surgical adjuvants used for internal limiting membrane peeling in idiopathic macular hole surgery